Blood cancer patients should continue BTKi therapy during COVID-19 vaccination

Post author:admin
Post published:April 2, 2025
Post category:uncategorized

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Public ignorance and apathy towards bird flu could hinder preventive efforts

Kewaunee & NuAire: Market Leaders Join Forces to Revolutionize the Industry

Study reveals long-term decision-making deficits due to heavy alcohol use

Helpful Links

Subscribe To Us